Focus: Market Access Policy
Amanda has 6 years’ experience in rare disease market access policy. She has led a number of projects related to shaping a supportive policy environment for medicines for rare and severe diseases. She holds a PhD in health psychology and worked on the orphan medicinal products workstream of the Horizon 2020 project ‘IMPACT-HTA: Improved methods and actionable tools for enhancing HTA.’
